Terms: = Brain cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Prognosis
352 results:
1. Prognostic stratification ability of the CPS+EG scoring system in her2-low and her2-zero early breast cancer treated with neoadjuvant chemotherapy.
Roussot N; Constantin G; Desmoulins I; Bergeron A; Arnould L; Beltjens F; Mayeur D; Kaderbhai C; Hennequin A; Jankowski C; Padeano MM; Costaz H; Jacinto S; Michel E; Amet A; Coutant C; Costa B; Jouannaud C; Deblock M; Levy C; Ferrero JM; Kerbrat P; Brain E; Mouret-Reynier MA; Coudert B; Bertaut A; Ladoire S
Eur J Cancer; 2024 May; 202():114037. PubMed ID: 38554542
[TBL] [Abstract] [Full Text] [Related]
2. Outcomes of the patients with metastatic male breast cancer.
Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
[TBL] [Abstract] [Full Text] [Related]
3. Protecting the brain: Novel Strategies for Preventing Breast cancer brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood-brain Barrier Models.
Kirchner J; Völker E; Shityakov S; Saji S; Förster CY
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542355
[TBL] [Abstract] [Full Text] [Related]
4. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
Strickland MR; Lander EM; Gibson MK; Ilson DH; Ajani JA; Klempner SJ
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38503041
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
6. Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with her2-enriched breast cancer.
Li Y; Qin J; Chen G; Wu W; Sun X
Int J Clin Oncol; 2024 Apr; 29(4):427-441. PubMed ID: 38411882
[TBL] [Abstract] [Full Text] [Related]
7. Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes.
Baccili Cury Megid T; Baskurt Z; Ma LX; Barron CC; Farooq A; Saltiel MP; Wang X; Bach Y; Ayoama H; Jang RW; Chen E; Veit-Haibach P; Wang B; Kalimuthu S; Cotton J; Wong R; Mesci A; Elimova E
J Neurooncol; 2024 Mar; 167(1):111-122. PubMed ID: 38372902
[TBL] [Abstract] [Full Text] [Related]
8. her2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study.
Prete AA; Angerilli V; Bergamo F; Vettore V; De Toni C; Intini R; Cerma K; Ricagno G; Cerantola R; Perissinotto E; De Rosa A; Ceccon C; Gasparello J; Denaro L; D'Amico A; Chioffi F; Carcea E; Fassan M; Lonardi S
Br J Cancer; 2024 May; 130(8):1316-1323. PubMed ID: 38347094
[TBL] [Abstract] [Full Text] [Related]
9. ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of her2-positive mammary tumorigenesis and metastasis.
Nie J; Dang S; Zhu R; Lu T; Zhang W
Breast Cancer Res; 2024 Jan; 26(1):19. PubMed ID: 38287441
[TBL] [Abstract] [Full Text] [Related]
10. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
11. Why does her2-positive breast cancer metastasize to the brain and what can we do about it?
Xu D; Hu Z; Wang K; Hu S; Zhou Y; Zhang S; Chen Y; Pan T
Crit Rev Oncol Hematol; 2024 Mar; 195():104269. PubMed ID: 38272149
[TBL] [Abstract] [Full Text] [Related]
12. New insights into her2-low breast cancer brain metastasis: A retrospective analysis.
Xu H; Wang Y; Li L; Han Y; Wu Y; Sa Q; Xu B; Wang J
Breast; 2024 Feb; 73():103669. PubMed ID: 38176304
[TBL] [Abstract] [Full Text] [Related]
13. Breast cancer brain Metastases: Achilles' Heel in Breast cancer Patients' Care.
Ferraro E; Seidman AD
Cancer Treat Res; 2023; 188():283-302. PubMed ID: 38175350
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract] [Full Text] [Related]
15. A novel treatment to enhance survival for end stage triple negative breast cancer using repurposed veterinary anthelmintics combined with gut‑supporting/immune enhancing molecules.
Iragavarapu-Charyulu V; Shakya R; Robinson P; Guzmán E; Tyulmenkova A; Pino JL; Isgor C
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131223
[TBL] [Abstract] [Full Text] [Related]
16. Systemic Treatment for brain Metastasis and Leptomeningeal Disease in Breast cancer Patients.
Puri S; Chaudhry A; Bayable A; Ganesh A; Daher A; Gadi VK; Maraka S
Curr Oncol Rep; 2023 Dec; 25(12):1419-1430. PubMed ID: 37924439
[TBL] [Abstract] [Full Text] [Related]
17. Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution.
Gonçalves DS; Santos AMRD; Costa SCVD; Costa RSD; Senna KMSE; Zimmermann IR
Rev Bras Epidemiol; 2023; 26():e230045. PubMed ID: 37878833
[TBL] [Abstract] [Full Text] [Related]
18. Anti-her2 Drugs for the Treatment of Advanced her2 Positive Breast cancer.
Stanowicka-Grada M; Senkus E
Curr Treat Options Oncol; 2023 Nov; 24(11):1633-1650. PubMed ID: 37878202
[TBL] [Abstract] [Full Text] [Related]
19. Association of the m
Li Y; Cao J; Wang J; Wu W; Jiang L; Sun X
Cancer; 2024 Feb; 130(3):356-374. PubMed ID: 37861451
[TBL] [Abstract] [Full Text] [Related]
20. Pyrotinib-based therapeutic approaches for her2-positive breast cancer: the time is now.
Qi X; Shi Q; Xuhong J; Zhang Y; Jiang J
Breast Cancer Res; 2023 Oct; 25(1):113. PubMed ID: 37789330
[TBL] [Abstract] [Full Text] [Related]
[Next]
